Objective: To characterize the expression and regulation of conjunctival mast cell surface receptors important in allergic inflammation.
C
ONJUNCTIVAL MAST cells and their mediators are implicated, at least in part, in all types of atopic ocular disease. Human studies of these ocular processes, however, primarily have consisted of pathological studies of biopsy specimens (demonstrating increased numbers of mast cells, eosinophils, and other inflammatory cells) and evaluation of tear film for mediators and cellular infiltration. [1] [2] [3] [4] [5] A method to isolate 6 and purify 7 human conjunctival mast cells from cadaveric donor tissue has been reported previously, and these mast cells have been shown not only to express message for tumor necrosis factor ␣ (TNF-␣), but also to release TNF-␣ protein. Release of TNF-␣ from challenged mast cells stimulates up-regulation of intercellular adhesion molecule-1 (ICAM-1) (CD54) on epithelial cells. 7 We herein expand on these findings by demonstrating that human conjunctival mast cell surface receptors (ckit, ICAM-1, and Fc⑀RI) and surfacebound IgE can be detected using flow cytometry and manipulated using incubation with the cytokines interleukin 4 (IL-4) and TNF-␣. This work gives us the potential to examine further the mechanisms of mast cell activation and survival and the role of the mast cell in the progression of ocular allergic inflammation to sight-threatening diseases such as atopic keratoconjunctivitis (AKC) and vernal keratoconjunctivitis (VKC).
RESULTS

MAST CELL PURIFICATION
The cell preparations consisted of 5% to 30% mast cells and 0.7 ϫ 10 6 to 1.0 ϫ 10 6 total cells per gram of conjunctival tissue digested. Contaminating cells were erythrocytes, mononuclear cells, and epithelial cells. The viability of the cell preparations was routinely greater than 85%.
FLOW CYTOMETRIC ANALYSIS OF MAST CELL SURFACE MARKERS
In the representative contour plots of unstimulated cells shown in Figure 1 , the percentage of total cells staining positive is indicated in each quadrant. Figure 1 surface-bound IgE (9.0% of total cells) (Figure 1, B) . Whereas other tryptase-negative cells in the preparation also stained positive for IgE (21.5% of total cells) ( Figure 1 , B), these cells were negative for Fc⑀RI. 
COMMENT
We have previously reported that isolated conjunctival mast cells release histamine on challenge with anti-IgE antibody, suggesting the presence of IgE bound to functional Fc⑀RI receptors on these cells. In the present study, we have identified the Fc⑀RI receptor on mast cells (tryptase-positive cells) using immunostaining combined with flow cytometry. Mast cells that stained positive for Fc⑀RI also stained positive for IgE. Some tryptase-negative cells (nonmast cells) in the preparation also stained positive for IgE, but were negative for Fc⑀RI. These cells are likely conjunctival epithelial cells or mononuclear cells with IgE bound to their surface. We have previously reported that purified conjunctival epithelial cells stain positive for IgE and the low-affinity IgE receptor CD23.
9
MATERIALS AND METHODS
REAGENTS AND SOLUTIONS
Collagenase (type I), hyaluronidase (type I-S), HEPES, trypan blue, Percoll (silica particles coated with polyvinyl pyrrolidone used for cell separation), fetal calf serum, RPMI 1640, gentamicin, penicillin, streptomycin, amphotericin B, Hanks balanced salt solution (without calcium, magesium, or phenol red) (HBSS), bovine serum albumin, sodium azide, and phenylmethyl sulfonyl fluoride were obtained from Sigma Chemical Company (St Louis, Mo). Wright stains were performed using a commercially available staining kit (Diff-Quik; Baxter Scientific Products, McGaw Park, Ill). Rabbit anti-chicken IgY-fluorescein isothiocyanate (FITC) polyclonal antibody, donkey antigoat IgG-phycoerythrin (PE) polyclonal antibody, and goat anti-mouse IgG-PE polyclonal antibody were obtained from Jackson ImmunoResearch (West Grove, Pa). Goat antihuman IgE polyclonal antibody was obtained from R&D Systems (Minneapolis, Minn). Sheep anti-human IgE-FITC polyclonal antibody was obtained from Serotec (Raleigh, NC). Mouse anti-human c-kit-PE monoclonal antibody and mouse anti-human ICAM-1-FITC monoclonal antibody were obtained from Pharmingen (San Diego, Calif). Isotype controls for flow cytometry were purchased from the same manufacturer as the respective specific antibodies. The chicken anti-human tryptase IgY polyclonal antibody was donated by Promega (Madison, Wis), and the mouse anti-human high-affinity IgE receptor chain (Fc⑀RI) monoclonal antibody was donated by Jarema Kochan, PhD, Hoffman LaRoche, Inc (Nutley, NJ).
The Tyrode physiological salt solution plus gelatin (TG) used in these studies consisted of 137-mmol/L sodium chloride, 2.6-mmol/L potassium chloride, 0.35-mmol/L sodium phosphate monobasic, 11.9-mmol/L sodium bicarbonate, 5.5-mmol/L glucose, and 1-g/L gelatin (adjusted to pH of 7.4 with hydrochloric acid). Calcium chloride, 2 mmol/L, and 1-mmol/L magnesium chloride were added to TG to make TGCM. Percoll stock solution was prepared by mixing the commercial Percoll solution and 10ϫ HEPES buffer plus deionized water to obtain an osmolality of 285 mOsm/kg water. The desired densities of Percoll were prepared by mixing the Percoll stock solution with TG to a density of 1.041 g/mL. Flow cytometry staining buffer (HBSS-BAP) consisted of HBSS, 1-g/L bovine serum albumin, 0.5-g/L sodium azide, and 18-mg/L phenylmethyl sulfonyl fluoride in 2 mL of ethanol. Mast cell culture medium consisted of RPMI 1640 supplemented with 20% fetal calf serum, 2.5-mmol/L L-glutamine, 400-µg/mL streptomycin, 20-µg/mL gentamicin, and 5-µg/mL amphotericin B.
MAST CELL ISOLATION, PURIFICATION, AND CULTURE
Human conjunctival mast cells were obtained as previously described. 7 Briefly, upper and lower bulbar conjunctivas were aseptically collected with permission within 8 hours (average time, 4.5 hours) of death from organ and tissue donors and transported in corneal preservation medium (Dexsol; Chiron Opthalmics, Irvine, Calif). Tissue acquisition protocols were approved by the University of Wisconsin Human Subjects Committee, Madison. On arrival, tissues were resuspended in mast cell culture medium, stored at 4°C, and equilibrated at 37°C overnight before isolation. A series of digestions (30 minutes at 37°C) with hyaluronidase and collagenase (2000 U/mL in TGCM) were used to disrupt tissue. Freed cells were collected, layered over single-density Percoll gradients (density, 1.041 g/mL), and centrifuged for 20 minutes at 400g. The resulting cell pellet was resuspended in mast cell culture medium, transferred to a 24-well plate (0.5 mL per well), and equilibrated at 37°C until the cells were resuspended in HBSS-BAP for surface receptor and/or intracellular tryptase staining. Mast cells were identified using flow cytometry with a mast cell-specific chicken Our findings of ICAM-1 and c-kit expression on conjunctival mast cells and their changes in expression in response to cytokine stimulation are consistent with what others have described using mast cell lines and mast cells from other tissues. [10] [11] [12] [13] [14] Intercellular adhesion molecule-1 is important for migration of inflammatory cells and antigen presentation, and it has been proposed that contact between mast cells and lymphocytes via ICAM-1 may result in mast cell degranulation. 15 Coculture of mast cells with murine T-cell hybridoma cells (activated by anti-CD3 antibody) has been shown to induce histamine release. 15 Mast cells cocultured with these activated T cells also had enhanced Fc⑀RI aggregationinduced degranulation, and this enhancement was inhibited by anti-ICAM-1 antibody. Frandji et al 16 demonstrated the importance of IL-4 in antigen presentation by mast cells with the observation that it could be enhanced by granulocyte-macrophage colonystimulating factor-cereberal spinal fluid only in combination with IL-4. As T cells appear to be a significant contributor to the pathological characteristics of AKC and VKC, greater understanding of mast cell-T-cell interactions would be beneficial in discerning the mechanisms of these diseases.
Incubation of conjunctival mast cells with IL-4 or TNF-␣ resulted in up-regulation of ICAM-1. Although TNF-␣ and IL-4 have been found in tear films of patients with allergic conjunctivitis, AKC, and VKC, the actual effect of these cytokines on the ocular surface is not known. Up-regulation of ICAM-1 by IL-4 has been described on cells of a human leukemic mast cell line, HMC-1.
14 It has been reported that IL-4 promotes the expression of leukocyte function-associated antigen-1 (CD11a) and ICAM-1 on cultured human cord blood mast cells, and that it induces homotypic aggregation of mast cells, which was completely blocked by anti-leukocyte functionassociated antigen-1 (CD11a) or ICAM-1 antibodies. 11 This suggests that IL-4 has an important role in interactions of mast cells with other inflammatory cells by upregulating mast cell adhesion molecules.
Recently it has been demonstrated that human conjunctival mast cells produce TNF-␣ and that conjunctival epithelial cell cultures incubated with supernatants from calcium ionophore (A23187)-stimulated mast cells anti-human tryptase IgY polyclonal antibody or mouse antihuman c-kit-PE monoclonal antibody. Differentiation of cells was determined on cytospins using Wright stain. Viability of cells was determined by trypan blue exclusion.
FLOW CYTOMETRIC ANALYSIS OF MAST CELLS
A 2-color immunostaining technique (FITC-vs PEconjugated antibodies) was used to double-label mast cells and identify surface receptors. In the immunostaining procedure, antibodies to 3 different mast cell-specific markers (intracellular tryptase, surface-expressed Fc⑀RI, and c-kit) along with antibodies to surface-expressed ICAM-1 and surface-bound IgE, were used. Cells were initially fixed and made permeable using a modification of the method published by Schmid et al, 8 to allow for intracellular staining of tryptase and mast cell identification. A chicken anti-human tryptase polyclonal antibody was used to label tryptase, and a rabbit anti-chicken IgY-FITC polyclonal second antibody was used to detect antitryptase-labeled cells. When mast cells were identified with anti-c-kit staining, intracellular staining for tryptase was not required (accordingly, cells were not fixed and made permeable), and propidium iodide was added to allow analysis of viable cells.
When anti-IgE staining was combined with Fc⑀RI, a goat anti-IgE polyclonal antibody was combined with a donkey anti-goat IgG-PE polyclonal second antibody. In other combinations, a sheep anti-human IgE-FITC polyclonal antibody was used. A mouse anti-human Fc⑀RI monoclonal antibody combined with a goat anti-mouse-PE polyclonal second antibody was used to detect Fc⑀RI. Mouse antihuman monoclonal antibodies against c-kit (PEconjugated) and ICAM-1 (FITC-conjugated) were used to detect these receptors. Species-and chromagenappropriate isotype antibody controls were included for each antibody used.
When a second antibody was used, cells were washed and resuspended in HBSS-BAP to a concentration of 1 ϫ 10 6 cells per milliliter (50 µL per tube). One of the following first antibodies was then added to these cells at a volume of 10 µL per tube: chicken anti-human tryptase polyclonal antibody (1:50 dilution in HBSS-BAP), 10-µg/mL mouse anti-human Fc⑀RI monoclonal antibody, or 10-µg/mL goat anti-human IgE polyclonal antibody. Rabbit IgG, donkey IgG, goat IgG, or mouse IgG, all 10 µL per tube (1:10 dilution of each in HBSS-BAP), was also added to block nonspecific binding of antibody. After incubation of the mixture for 30 minutes (shaking ice bath), the cells were washed twice in 2 mL of HBSS-BAP and then resuspended in rabbit anti-chicken IgY-FITC polyclonal second antibody (1:50 dilution in HBSS-BAP) and PE-conjugated goat anti-mouse IgG-PE polyclonal antibody or donkey anti-goat IgG-PE polyclonal antibody (100 µL per tube). After a second 30-minute incubation, the cells were washed and resuspended in HBSS-BAP (500 µL per tube) for analysis using a commercially available flow cytometer (FACScan; Becton Dickinson, San Jose, Calif). When directly conjugated antibodies were used, the cells were resuspended after isolation, incubated with 10 µL per tube of anti-surface receptor antibodies (PEand FITC-conjugated), and prepared for flow cytometry. The cells were analyzed via dot-plots for PE vs FITC staining.
CYTOKINE REGULATION OF MAST CELL c-kit, ICAM-1, AND IgE
To study the effect of cytokines on mast cell surface receptors, semipurified conjunctival mast cell preparations were incubated overnight (37°C) with recombinant TNF-␣ or IL-4 (200 U/mL) or alone in mast cell medium. The cells were then resuspended for flow cytometry and doublestained with a mouse anti-human c-kit-PE monoclonal antibody vs a mouse anti-human ICAM-1-FITC monoclonal antibody or a sheep anti-human IgE-FITC polyclonal antibody. The cells were analyzed using histograms to evaluate c-kit-positive cells. had increased levels of ICAM-1 on their surface. 7 Tumor necrosis factor ␣ up-regulates ICAM-1, 17, 18 and conjunctival epithelial cells have been shown to release TNF-␣. 19 This TNF-␣ release from conjunctival mast cells and/or epithelial cells may be an important mechanism of autocrine regulation of conjunctival adhesion receptors. In our study, TNF-␣ and IL-4 were added to a mixed culture of cells (primarily mast cells and epithelial cells) containing an undefined combination of cell mediators from all cell types present (but presumably similar to the environment from which they were isolated). Accordingly, the responses observed may or may not be due to a direct effect of the cytokine added.
Interestingly, our research showed down-regulation of c-kit following incubation with IL-4, which is in agreement with the finding of down-regulation of c-kit messenger RNA expression by IL-4 in leukemic myeloid cells and HMC-1 cells. 12 This may be part of a negative feedback mechanism and prominent in the resolution of the acute allergic response in the conjunctiva. Mast cell c-kit receptor ligation to stem cell factor is known to be critical to mast cell survival, but the in vivo results of this ligation are not well understood. Murine fibroblasts have been shown in vitro to aggregate mast cells via membranebound stem cell factor, presumably facilitating mast cell differentiation and survival. 13 If these interactions between mast cells and fibroblasts happen in vivo and collagen release is a result, this could be a critical aspect of the conjunctival scarring in AKC, which is due to collagen release from fibroblasts. 2 The basis for the increase in surface-bound IgE levels following IL-4 or TNF-␣ incubation is not fully understood. Two possible explanations are increased availability of IgE and/or an increase in the absolute number of Fc⑀RI receptors. It has been reported that IL-4 induces Fc⑀RI receptors on human mast cells. 20 The array of surface receptors expressed on mast cells has not been thoroughly characterized. We believe the ability to measure and manipulate these receptors on freshly isolated cells gives us the unique opportunity to study mast cell interactions with other isolated cells in vitro as a model of ocular inflammation. This model could be a useful tool to examine the effects of mast cellstabilizing drugs on cytokine-induced regulation of expression and mechanism of sight-threatening disease.
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